September 4, 2018 09:47 AM EDT

Brainstorm recruits Novartis vet Araya as chief commercial officer; Roche out-licenses IPF drug to Shanghai's Ark

John Carroll

Editor & Founder

→ BrainStorm Cell Therapeutics $BCLI has appointed Novartis vet Arturo Araya as chief commercial officer. Araya had been global head of commercial …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Brainstorm recruits Novartis vet Araya as chief commercial officer; Roche out-licenses IPF drug to Shanghai's Ark

John Carroll

Editor & Founder

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Novo Nordisk is feeling the competition from compounded GLP-1s, exec says

Kura's AML drug passes key study in advanced patients, plans next steps with FDA and newly diagnosed studies

Amgen announces hold on Phase 1 obesity candidate, pipeline cuts

Small personalized vaccine trial sees progress in late-stage kidney cancer

EyePoint shares more mid-stage data for therapy trying to compete with Regeneron's Eylea

Pfizer says it has at least $10B available for deals in 2025, with a focus on pipeline

Brain­storm re­cruits No­var­tis vet Araya as chief com­mer­cial of­fi­cer; Roche out-li­cens­es IPF drug to Shang­hai's Ark

Editor & Founder

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Brainstorm recruits Novartis vet Araya as chief commercial officer; Roche out-licenses IPF drug to Shanghai's Ark